OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
30/11/2025
Voltar para busca
Dado oficial do USPTO
BIONTECH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Snapshot rápido
ST13
US500000079353523Classe
1, 5, 9, 10, 35, 42, 44
Pedido
79353523
Registro
7166547
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
01/12/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 9, 10, 35, 42, 44
Data de depósito
28/12/2021
Data de registro
19/09/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/09/2023
Última transação
01/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
03
Localização do titular
DE
Examinador
REGAN,JOHN B
Unidade examinadora
M40
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of stylized letters reading "BIONTECH" wherein the "B", "I", "O", "E", "C" and "H" appear in dark green color and the "N" and "T" appear in light green color.
Titulares e representantes
Titulares
B. S. (pessoa física)
Representantes
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in pharmaceutical industry; active chemical ingredients for use in manufacture of anti-cancer drugs and vaccines; adjuvants for use in manufacture of vaccines; nucleic acidsproteins and peptides for laboratory use; diagnostic preparations for scientific or research use other than for medical purposes
Classe 5
Pharmaceutical products for the prevention and treatment of cancerinfectious diseasesimmunological diseasesexcept vitamin preparationsmineral food supplementsprobioticsomega 3 preparationsdietetic substances and food supplements for medical and non-medical purposes; Vaccines; Chemical reagents used for medical purposes; Biochemical reagents used for purposes for the treatment of cancertreatment of immunological diseasestreatment of infectious diseases; Macromoleculesnucleic acid sequences and proteinsused for medical and veterinary purposes; cell based immune therapeutics for treatment of cancertreatment of immunological diseasestreatment of infectious diseases; diagnostic preparations for clinical or medical laboratory use
Classe 9
Downloadable mobile applications for enabling healthcare professionals and patients to access information on pharmaceuticalmedical and vaccine products and services; downloadable computer software for enabling healthcare professionals and patients to access information on pharmaceuticalmedical and vaccine products and services; downloadable e-commerce computer software for enabling users to perform electronic business transactions via a global computer network
Classe 10
Medical diagnostic devices for analysis of body fluids and biopsies for diagnosis and monitoring of cancerinfectious diseasesimmunological diseases; medical diagnostic devices for analysis of body fluids and biopsies for patient stratification
Classe 35
Business advisory services in the field of electronic commerce; providing business information in the field of electronic commerce; providing business informationcustomer information on pharmaceutical and medical products through an on-line computer network; wholesale and retail store services featuring pharmaceutical productsmedicinal preparationsmedical supplies
Classe 42
medical and scientific research in the field of treatment of immunological diseasescancer treatmenttreatment of infectious diseases; providing medical and scientific research informationconsultancyadvisory servicesall in the fields of medical and scientific research in the field of treatment of immunological diseasescancer treatmenttreatment of infectious diseases; medical and scientific research services by compiling data for clinical trials and drug admission
Classe 44
Medicalhygienic and beauty care; healthcare services; provision of medical information and services; provision of medical information to patients and healthcare professionals concerning pharmaceutical productsvaccinesmedical productsmedical diseases and disorders and related treatments via the Internet; medical services in the field of gene therapy; medical services in the field of cell therapy; medical and health care services; medical servicesproviding therapies for treating cancerinfectious diseases and immunological diseases; veterinary servicesproviding therapies for treating cancerinfectious diseasesimmunological diseases; medical and pharmaceutical consultation; medical diagnostic testingmonitoring and reporting services; genetic testing for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/11/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/11/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
31/01/2025
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
26/08/2024
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
17/06/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/01/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
21/12/2023
FIMP
FINAL DISPOSITION PROCESSED
21/12/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
19/12/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
25/09/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25/09/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25/09/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
19/09/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
19/09/2023
GPNX
NOTIFICATION PROCESSED BY IB
11/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/07/2023
PUBO
PUBLISHED FOR OPPOSITION
04/07/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
21/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/06/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14/06/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/05/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
03/05/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/05/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
03/05/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/03/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/03/2023
RFNT
REFUSAL PROCESSED BY IB
15/02/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
20/01/2023
RFRR
REFUSAL PROCESSED BY MPU
20/01/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/11/2022
CNRT
NON-FINAL ACTION WRITTEN
14/11/2022
MAFR
APPLICATION FILING RECEIPT MAILED
11/11/2022
DOCK
ASSIGNED TO EXAMINER
07/11/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/11/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
01/11/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
27/10/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIONTECH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.